The evolutionary loss of metabolic capabilities sometimes leaves modern humans vulnerable to conditions that our distant ancestors may never have encountered. Such is the case with hyperuricemia, the pathological accumulation of uric acid in human tissues that underlies gout and several related metabolic disorders. Recent investigations at Georgia State University have now employed CRISPR-Cas9 gene-editing…